Alliance

C4U and TAUNS Laboratories enter into Joint Development and Commercialization Agreement

C4U and TAUNS Laboratories, Inc. have entered into the agreement for the joint development and commercialization of novel coronavirus SARS-CoV-2 diagnostics using CRISPR-Cas3 genome editing technology.